{
  "conservative": {
    "name": "Conservative Scenario",
    "totalInvestment": 8.5,
    "productionLines": 8,
    "linesIncluded": [1, 2, 4, 16, 17, 18, 20, 21],
    "revenueImpact": 35,
    "paybackPeriod": 4.5,
    "riskLevel": "Low",
    "marketPosition": "Ethiopia Focus",
    "description": "Focus on critical GMP compliance and safety improvements for domestic market stability",
    "keyBenefits": [
      "Immediate GMP compliance for core products",
      "Reduced operational risk",
      "Stable domestic market position",
      "Lower financial exposure"
    ],
    "considerations": [
      "Limited regional expansion capability",
      "Slower revenue growth",
      "May miss market opportunities"
    ]
  },
  "moderate": {
    "name": "Moderate Scenario",
    "totalInvestment": 15.2,
    "productionLines": 15,
    "linesIncluded": [1, 2, 3, 4, 5, 8, 11, 15, 16, 17, 18, 19, 20, 21, 23],
    "revenueImpact": 65,
    "paybackPeriod": 3.8,
    "riskLevel": "Medium",
    "marketPosition": "EAC Expansion",
    "description": "Balanced approach targeting East African Community market with key vaccine and pharmaceutical lines",
    "keyBenefits": [
      "Full GMP compliance achieved",
      "Regional market penetration",
      "Diversified product portfolio",
      "Strong competitive position in EAC"
    ],
    "considerations": [
      "Requires skilled workforce expansion",
      "Moderate financial commitment",
      "Regulatory compliance in multiple countries"
    ]
  },
  "aggressive": {
    "name": "Aggressive Scenario",
    "totalInvestment": 24.7,
    "productionLines": 23,
    "linesIncluded": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23],
    "revenueImpact": 120,
    "paybackPeriod": 3.2,
    "riskLevel": "High",
    "marketPosition": "Regional Leader",
    "description": "Comprehensive modernization for pan-African market leadership and AU PANVAC partnership",
    "keyBenefits": [
      "Complete facility modernization",
      "Pan-African market leadership",
      "AU PANVAC strategic partnership",
      "Maximum revenue potential",
      "Full product portfolio capability"
    ],
    "considerations": [
      "Significant capital requirement",
      "Complex implementation timeline",
      "High operational complexity",
      "Requires substantial workforce development"
    ]
  }
}
